Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Webb

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
International Journal of Pharmaceutics|March 1, 2026
Translating in vitro buccal permeation to in vivo and whole‑body exposure using in silico cell‑based and physiologically-based pharmacokinetic modellingSean M Edwards, Amy L Harding, Joseph A Leedale, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 25, 2019
Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathwayLauren Tomlinson, Zhen Qi Lu, Robert A Bentley, et al.
Interface Focus|March 21, 2020
Multiscale modelling of drug transport and metabolism in liver spheroidsJoseph A Leedale, Jonathan A Kyffin, Amy L Harding, et al.
Iscience|September 22, 2018
A Combined In Vitro/In Silico Approach to Identifying Off-Target Receptor ToxicityJoseph Leedale, Kieran J Sharkey, Helen E Colley, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 23, 2018
A critical review of adverse effects to the kidney: mechanisms, data sources, and in silico tools to assist predictionJulia Pletz, Steven J Enoch, Diviya M Jais, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|April 23, 2019
CD28 Superagonistic Activation of T Cells Induces a Tumor Cell-Like Metabolic ProgramThilipan Thaventhiran, Wai Wong, Ahmad F Alghanem, et al.
Mabs|December 18, 2014
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonistThilipan Thaventhiran, Naif Alhumeed, Han X A Yeang, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
International Journal of Pharmaceutics|March 1, 2026
Translating in vitro buccal permeation to in vivo and whole‑body exposure using in silico cell‑based and physiologically-based pharmacokinetic modellingSean M Edwards, Amy L Harding, Joseph A Leedale, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 25, 2019
Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathwayLauren Tomlinson, Zhen Qi Lu, Robert A Bentley, et al.
Interface Focus|March 21, 2020
Multiscale modelling of drug transport and metabolism in liver spheroidsJoseph A Leedale, Jonathan A Kyffin, Amy L Harding, et al.
Iscience|September 22, 2018
A Combined In Vitro/In Silico Approach to Identifying Off-Target Receptor ToxicityJoseph Leedale, Kieran J Sharkey, Helen E Colley, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 23, 2018
A critical review of adverse effects to the kidney: mechanisms, data sources, and in silico tools to assist predictionJulia Pletz, Steven J Enoch, Diviya M Jais, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|April 23, 2019
CD28 Superagonistic Activation of T Cells Induces a Tumor Cell-Like Metabolic ProgramThilipan Thaventhiran, Wai Wong, Ahmad F Alghanem, et al.
Mabs|December 18, 2014
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonistThilipan Thaventhiran, Naif Alhumeed, Han X A Yeang, et al.
Pageof 4